Apeloa Pharmaceutical Co.,Ltd
000739
Rang în acțiuni
#4342
Apeloa Pharmaceutical Co.,Ltd operates as a comprehensive pharmaceutical... Apeloa Pharmaceutical Co.,Ltd operates as a comprehensive pharmaceutical enterprise, specializing in the discovery, development, production, and global distribution of a diverse range of medicinal products. Its market reach spans China and various international territories. The company strategically focuses its product portfolio on several critical medical fields, including cardiovascular and cerebrovascular health, anti-infective treatments, antiviral therapies, and oncology (cancer treatment), alongside other therapeutic categories. Apeloa's offerings encompass finished pharmaceutical preparations, raw material intermediates (active pharmaceutical ingredients and their precursors), and veterinary medicines. These products are primarily recognized and sold under key brands such as Tianliwei, Beshin, Yosemade, and Jutai, among others. Furthermore, the company extends its expertise to other pharmaceutical businesses by providing contract research, development, and manufacturing (CDMO) services. The corporate headquarters for Apeloa Pharmaceutical Co.,Ltd are located in Dongyang, China.
Preț acțiune
$3.06
Capitalizare de piață
$3.55B
Schimbare (1 zi)
-3.45%
Schimbare (1 an)
43.57%
Țară
CN
Tranzacționează Apeloa Pharmaceutical Co.,Ltd (000739)
Categorie
Healthcare
Raport P/S pentru Apeloa Pharmaceutical Co.,Ltd (000739)
Raport P/S la data de October 2026 TTM: 3.02
Conform celor mai recente rapoarte financiare și prețului acțiunilor Apeloa Pharmaceutical Co.,Ltd, raportul P/S actual (TTM) este 3.02. La sfârșitul anului 2023, compania avea un P/S de 1.58.
Istoricul raportului P/S pentru Apeloa Pharmaceutical Co.,Ltd din 2000 până în 2026
Raport P/S la sfârșitul fiecărui an
| An | Raport P/S | Schimbă |
|---|---|---|
| 2026 (TTM) | 3.02 | 92.23% |
| 2024 | 1.57 | -0.75% |
| 2023 | 1.58 | -33.91% |
| 2022 | 2.39 | -48.35% |
| 2021 | 4.62 | 32.81% |
| 2020 | 3.48 | 64.26% |
| 2019 | 2.12 | 54.78% |
| 2018 | 1.37 | 1.75% |
| 2017 | 1.35 | -25.37% |
| 2016 | 1.80 | -16.80% |
| 2015 | 2.17 | 10.98% |
| 2014 | 1.95 | 91.95% |
| 2013 | 1.02 | 118.48% |
| 2012 | 0.47 | -78.84% |
| 2011 | 2.20 | 42.46% |
| 2010 | 1.55 | -17.73% |
| 2009 | 1.88 | 119.94% |
| 2008 | 0.85 | -67.41% |
| 2007 | 2.62 | 128.30% |
| 2006 | 1.15 | 105.61% |
| 2005 | 0.56 | -31.73% |
| 2004 | 0.82 | -9.78% |
| 2003 | 0.91 | -43.62% |
| 2002 | 1.61 | -86.69% |
| 2001 | 12.08 | 16.98% |
| 2000 | 10.33 | 0.00% |
Raport P/S pentru companii similare sau competitoare
| Companie | Raport P/S | Diferență raport P/S | Țara |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| - | - |
JP
|
|
| - | - |
CH
|
|
| 7.06 | 133.86% |
IN
|
